NBW Capital’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.52M Sell
20,221
-211
-1% -$26.9K 0.54% 60
2025
Q1
$2.6M Sell
20,432
-4,762
-19% -$733K 0.58% 61
2024
Q4
$3.63M Buy
25,194
+4,152
+20% +$595K 0.67% 62
2024
Q3
$3.13M Sell
21,042
-15,025
-42% -$2.15M 0.59% 61
2024
Q2
$4.55M Buy
36,067
+2,451
+7% +$384K 0.9% 51
2024
Q1
$6.18M Buy
33,616
+578
+2% +$110K 1.26% 34
2023
Q4
$5.94M Buy
33,038
+2,650
+9% +$413K 1.3% 30
2023
Q3
$4.83M Buy
30,388
+565
+2% +$92.4K 1.18% 41
2023
Q2
$4.22M Buy
29,823
+1,692
+6% +$271K 0.98% 49
2023
Q1
$4.74M Buy
28,131
+8,468
+43% +$1.51M 1.15% 40
2022
Q4
$3.33M Sell
19,663
-4,861
-20% -$882K 0.85% 57
2022
Q3
$4.59M Buy
24,524
+4,251
+21% +$896K 1.23% 34
2022
Q2
$3.29M Sell
20,273
-454
-2% -$71.8K 0.9% 57
2022
Q1
$3.9M Sell
20,727
-141
-0.7% -$26.8K 0.93% 53
2021
Q4
$5.53M Buy
20,868
+956
+5% +$258K 1.23% 38
2021
Q3
$5.75M Sell
19,912
-6,246
-24% -$1.6M 1.39% 28
2021
Q2
$5.22M Buy
26,158
+794
+3% +$154K 1.27% 35
2021
Q1
$4.93M Buy
25,364
+5,970
+31% +$1.22M 1.36% 32
2020
Q4
$3.72M Sell
19,394
-9,697
-33% -$1.76M 1.13% 39
2020
Q3
$4.29M Buy
29,091
+2,086
+8% +$298K 1.43% 32
2020
Q2
$3.34M Sell
27,005
-13,389
-33% -$1.58M 1.2% 36
2020
Q1
$3.9M Sell
40,394
-2,466
-6% -$238K 1.86% 15
2019
Q4
$3.96M Sell
42,860
-369
-0.9% -$31K 1.13% 42
2019
Q3
$3.31M Buy
43,229
+7,830
+22% +$685K 0.99% 47
2019
Q2
$3.04M Sell
35,399
-542
-2% -$36.9K 0.84% 52
2019
Q1
$2.12M Sell
35,941
-164
-0.5% -$9.43K 0.58% 61
2018
Q4
$1.9M Buy
36,105
+318
+0.9% +$18.6K 0.68% 53
2018
Q3
$1.99M Sell
35,787
-12,671
-26% -$653K 0.53% 65
2018
Q2
$2.28M Buy
48,458
+640
+1% +$26.3K 0.65% 60
2018
Q1
$1.73M Buy
47,818
+4,373
+10% +$154K 0.54% 59
2017
Q4
$1.58M Sell
43,445
-371
-0.8% -$13.4K 0.41% 64
2017
Q3
$1.68M Sell
43,816
-93
-0.2% -$3.9K 0.46% 62
2017
Q2
$1.82M Buy
43,909
+21,254
+94% +$808K 0.51% 61
2017
Q1
$797K Buy
22,655
+118
+0.5% +$3.74K 0.22% 61
2016
Q4
$695K Buy
22,537
+355
+2% +$11K 0.2% 65
2016
Q3
$670K Sell
22,182
-36
-0.2% -$1.09K 0.19% 67
2016
Q2
$608K Sell
22,218
-21,797
-50% -$557K 0.19% 64
2016
Q1
$1.18M Sell
44,015
-990
-2% -$24.2K 0.37% 60
2015
Q4
$1.27M Sell
45,005
-3,695
-8% -$107K 0.39% 64
2015
Q3
$1.36M Buy
+48,700
New +$1.76M 0.4% 70

Other funds holding RGEN

NBW Capital's RGEN Position: Q2 2025 in Review

NBW Capital reduced its Repligen (RGEN) stake by 1% in Q2 2025, selling an estimated $26.9K and leaving 20,221 shares worth $2.52M. The position accounts for 0.54% of the portfolio, ranked #60.

NBW Capital first reported a position in RGEN in Q3 2015 and has held it in 40 quarters since. The position peaked at $6.18M in Q1 2024. 444 funds tracked by Wall St. Rank hold RGEN as of Q2 2025.

  • NBW Capital held 20,221 shares of Repligen worth $2.52M as of Q2 2025.
  • NBW Capital sold 211 Repligen shares in Q2 2025, an estimated $26.9K.
  • Repligen made up 0.54% of NBW Capital's portfolio in Q2 2025, its #60 holding.
  • NBW Capital first reported a position in Repligen in Q3 2015 and has held it in 40 quarters since.
  • NBW Capital's Repligen position peaked at $6.18M in Q1 2024.
  • 444 funds tracked by Wall St. Rank held Repligen as of Q2 2025.

Based on NBW Capital's 13F filing for Q2 2025, filed 13 Aug 2025.